Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dual Inhibitions on Glucose/Glutamine Metabolisms for Nontoxic Pancreatic Cancer Therapy
Yingying Xu, Zhiguo Yu, Hao Fu, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 19, pp. 21836-21847
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Recent progress in the development of nanomaterials targeting multiple cancer metabolic pathways: a review of mechanistic approaches for cancer treatment
Ling Zhang, Bing-Zhong Zhai, Yuejin Wu, et al.
Drug Delivery (2023) Vol. 30, Iss. 1, pp. 1-18
Open Access | Times Cited: 28
KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression
Zining Zhang, Heng Zhang, Xiang Liao, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 28
The role of metabolic reprogramming in pancreatic cancer chemoresistance
Chang Liu, Changfeng Li, Yuanda Liu
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 22
Anti‐Acidification and Immune Regulation by Nano‐Ceria‐Loaded Mg–Al Layered Double Hydroxide for Rheumatoid Arthritis Therapy
Hao Fu, Yuedong Guo, Wenming Fang, et al.
Advanced Science (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 18
A PD‐L1‐targeting Regulator for Metabolic Reprogramming to Enhance Glutamine Inhibition‐Mediated Synergistic Antitumor Metabolic and Immune Therapy
Xiao‐Kang Jin, Shi‐Man Zhang, Jun‐Long Liang, et al.
Advanced Materials (2023) Vol. 36, Iss. 6
Open Access | Times Cited: 14
The role of amino acid metabolism alterations in pancreatic cancer: From mechanism to application
Shenao Fu, Shaokang Xu, Shubing Zhang
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188893-188893
Closed Access | Times Cited: 13
Recent advances in nanomedicine for metabolism-targeted cancer therapy
Jun Da, Xinjia Di, Yuqi Xie, et al.
Chemical Communications (2024) Vol. 60, Iss. 18, pp. 2442-2461
Closed Access | Times Cited: 5
Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets
Ding Nan, Weiping Yao, Luanluan Huang, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Long non-coding RNAs: Emerging regulators of invasion and metastasis in pancreatic cancer
Mengmeng Shi, Rui Zhang, Hui Lyu, et al.
Journal of Advanced Research (2025)
Open Access
Nutrient transporter-oriented nanoinhibitor counteracts intracellular metabolic reprogramming for RT-resistant HCC treatment
Yuehua Wang, Zhenjie Wang, Mengnan Liu, et al.
Materials Today Bio (2025) Vol. 31, pp. 101608-101608
Open Access
Nanomedicines Targeting Metabolic Pathways in the Tumor Microenvironment: Future Perspectives and the Role of AI
Shuai Fan, Wenyu Wang, Wieqi Che, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 201-201
Open Access
Recent advances in targeted gene silencing and cancer therapy by nanoparticle-based delivery systems
Hongyan Liu, Xialin Zhu, Yuyan Wei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 114065-114065
Open Access | Times Cited: 19
A 2D self-cascade catalytic system based on CoCuFe-LDH nanosheets for accelerated healing of infected wounds
Jinyao Zheng, Zongjia Li, Juan Qin, et al.
Chemical Engineering Journal (2024) Vol. 495, pp. 153298-153298
Closed Access | Times Cited: 4
Design Strategies of Tumor‐Targeted Delivery Systems Based on 2D Nanomaterials
Lin Ding, Minli Liang, Chenchen Li, et al.
Small Methods (2022) Vol. 6, Iss. 11
Closed Access | Times Cited: 16
Regulation of metabolism in pancreatic ductal adenocarcinoma via nanotechnology-enabled strategies
Zhiqin Wang, Bowen Wu, Guangjun Nie, et al.
Cancer Letters (2023) Vol. 560, pp. 216138-216138
Closed Access | Times Cited: 9
Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis
Shanzay Ahmed, Christopher B. Mahony, Alyssa Torres, et al.
Arthritis Research & Therapy (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 9
SMARCA5 reprograms AKR1B1-mediated fructose metabolism to control leukemogenesis
Peng-Cheng Yu, Dan Hou, Binhe Chang, et al.
Developmental Cell (2024) Vol. 59, Iss. 15, pp. 1954-1971.e7
Closed Access | Times Cited: 3
Participation of protein metabolism in cancer progression and its potential targeting for the management of cancer
Dalong Liu, Yun Wang, Xiaojiang Li, et al.
Amino Acids (2023) Vol. 55, Iss. 10, pp. 1223-1246
Closed Access | Times Cited: 7
Gemcitabine nano-prodrug reprograms intratumoral metabolism and alleviates immunosuppression for hepatocellular carcinoma therapy
Yuehua Wang, Bingchen Zhang, Qiye Xi, et al.
Nano Today (2023) Vol. 53, pp. 102009-102009
Closed Access | Times Cited: 6
Reallocating Cell Respiration Substrates for Cancer Therapy Using a Metabolism Regulator with an Intermembrane‐Translocatable Accessory
Qiu‐Yi Duan, Ya‐Xuan Zhu, Bai‐Hui Shan, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 23
Closed Access | Times Cited: 5
Metabolism and structure of PDA as the target for new therapies: possibilities and limitations for nanotechnology
Adrianna Zygmunt, Jerzy Gubernator
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 6, pp. 845-865
Closed Access | Times Cited: 1
Targeting aberrant amino acid metabolism for pancreatic cancer therapy: Opportunities for nanoparticles
Xinlong Zang, Ke Lei, Jia Wang, et al.
Chemical Engineering Journal (2024) Vol. 498, pp. 155071-155071
Closed Access | Times Cited: 1
Nrf2 regulates the activation-driven expansion of CD4+T-cells by differentially modulating glucose and glutamine metabolism
Aprajita Tripathi, Debolina Dasgupta, Anil Pant, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Nrf2 Regulates the Activation-Driven Expansion of CD4 T-Cells by Differentially Modulating Glucose and Glutamine Metabolism
Aprajita Tripathi, Debolina Dasgupta, Anil Pant, et al.
(2024)
Open Access
Nephropathy induced by cisplatin results from mitochondrial disruption, impaired energy metabolism, altered expression of renal transporters, and accumulation of urinary toxins
Mingkang Zhang, Jianping Zhang, Yanrong Ma, et al.
Journal of Trace Elements in Medicine and Biology (2024) Vol. 86, pp. 127553-127553
Closed Access
Page 1 - Next Page

Scroll to top